BOSTON ADVISORS LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$737,000
+60.2%
37,905
+37.2%
0.02%
+90.0%
Q4 2017$460,000
-15.3%
27,635
+3.3%
0.01%
-16.7%
Q3 2017$543,000
+59.7%
26,750
+127.0%
0.01%
+50.0%
Q2 2016$340,000
-8.8%
11,785
+1.1%
0.01%
-11.1%
Q1 2016$373,000
-25.3%
11,6600.0%0.01%
-25.0%
Q4 2015$499,00011,6600.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Aravt Global 2,670,000$125,143,0009.40%
Krensavage Asset Management, LLC 410,944$19,261,0008.77%
BANBURY PARTNERS LLC 292,660$13,717,0008.70%
Slate Path Capital LP 1,935,000$90,693,0005.72%
BLUE JAY CAPITAL MANAGEMENT, LLC 285,000$13,358,0004.69%
Orbimed Advisors 6,678,000$312,998,0002.67%
Pennant Capital Management, LLC 2,025,000$94,912,0001.78%
Iguana Healthcare Management, LLC 75,000$3,515,0001.48%
Leonard Capital Management, Inc. 89,235$4,182,0001.44%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$11,718,0001.23%
View complete list of IMPAX LABORATORIES INC shareholders